These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9862691)

  • 1. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4.
    Gilfillan S; Shen X; König R
    J Immunol; 1998 Dec; 161(12):6629-37. PubMed ID: 9862691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coreceptor-independent T cell activation in mice expressing MHC class II molecules mutated in the CD4 binding domain.
    Mostaghel EA; Riberdy JM; Steeber DA; Doyle C
    J Immunol; 1998 Dec; 161(12):6559-66. PubMed ID: 9862682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
    Maroto R; Shen X; König R
    J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
    Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
    J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of intraepithelial lymphocytes from major histocompatibility complex (MHC)-deficient mice: no evidence for a role of MHC class II antigens in the positive selection of V delta 4+ gamma delta T cells.
    Schleussner C; Ceredig R
    Eur J Immunol; 1993 Jul; 23(7):1615-22. PubMed ID: 8391987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD4 residue Phe 43 is critical for repertoire development and maturation of MHC class II restricted CD4 single-positive T lineage cells in vivo.
    Sakihama T; Hunsicker ME; Hussey RE; Reinherz EL
    Eur J Immunol; 2000 Jan; 30(1):279-90. PubMed ID: 10602051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
    Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B
    J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and function of CD4+ T cells in mice lacking invariant chain.
    Wong P; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2133-42. PubMed ID: 8690902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells.
    Shen X; König R
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):87-96. PubMed ID: 11292263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles.
    Fleury S; Huang B; Zerbib A; Croteau G; Long EO; Sekaly RP
    J Immunol; 1996 Mar; 156(5):1848-55. PubMed ID: 8596036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
    Doukas J; Pober JS
    J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.